References
- Craparo, E. F. and M. L. Bondi. 2012. Application of polymeric nanoparticles in immunotherapy. Curr. Opin. Allergy Clin. Immunol. 12: 658-664. https://doi.org/10.1097/ACI.0b013e3283588c57
- Smith, D. M., J. K. Simon, and J. R. Baker, Jr. 2013. Applications of nanotechnology for immunology. Nat. Rev. Immunol. 13: 592-605. https://doi.org/10.1038/nri3488
- Serda, R. E. 2013. Particle platforms for cancer immunotherapy. Int. J. Nanomedicine 8: 1683-1696.
- Rodriguez-Limas, W. A., K. Sekar, and K. E. Tyo. 2013. Virus-like particles: the future of microbial factories and cell-free systems as platforms for vaccine development. Curr. Opin. Biotechnol. In press: http://dx.doi.org/10.1016/j.copbio. 2013.02.008.
- Yuba, E., A. Harada, Y. Sakanishi, S. Watarai, and K. Kono. 2013. A liposome-based antigen delivery system using pH-sensitive fusogenic polymers for cancer immunotherapy. Biomaterials 34: 3042-3052. https://doi.org/10.1016/j.biomaterials.2012.12.031
- Syed, S., A. Zubair, and M. Frieri. 2013. Immune response to nanomaterials: implications for medicine and literature review. Curr. Allergy. Asthma Rep. 13: 50-57. https://doi.org/10.1007/s11882-012-0302-3
- Ditto, A. J., P. N. Shah, and Y. H. Yun. 2009. Non-viral gene delivery using nanoparticles. Expert. Opin. Drug Deliv. 6: 1149-1160. https://doi.org/10.1517/17425240903241796
- Hua, S. and P. J. Cabot. 2013. Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition. Pain Physician 16: E199-216.
- Gregory, A. E., R. Titball, and D. Williamson. 2013. Vaccine delivery using nanoparticles. Front Cell Infect. Microbiol. 3:1-13. doi: 10.3389/fcimb.2013.00013
- Hadinoto, K., A. Sundaresan, and W. S. Cheow. 2013. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review. Eur. J. Pharm. Biopharm. In press : http://dx.doi.org/10.1016/j.ejpb.2013.07.
- Pawar, D., S. Mangal, R. Goswami, and K. S. Jaganathan. 2013. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: Effect of mucoadhesive coating on antigen uptake and immune adjuvant activity. Eur. J. Pharm. Biopharm. In press : http://dx.doi. org/10.1016/j.ejpb.2013.06.017
- DeMuth, P. C., J. J. Moon, H. Suh, P. T. Hammond, and D. J. Irvine. 2012. Releasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery. ACS Nano 6: 8041-8051. https://doi.org/10.1021/nn302639r
- Lee, J. S., D. H. Kim, C. M. Lee, T. K. Ha, K. T. Noh, J. W. Park, D. R. Heo, K. H. Son, I. D. Jung, E. K. Lee, Y. K. Shin, S. C. Ahn, and Y. M. Park. 2011. Deoxypodophyllotoxin induces a Th1 response and enhances the antitumor efficacy of a dendritic cell-based vaccine. Immune Netw. 11: 79-94. https://doi.org/10.4110/in.2011.11.1.79
- Noh, K. T., S. J. Shin, K. H. Son, I. D. Jung, H. K. Kang, S. J. Lee, E. K. Lee, Y. K. Shin, J. C. You, and Y. M. Park. 2012. The Mycobacterium avium subsp. paratuberculosis fibronectin attachment protein, a toll-like receptor 4 agonist, enhances dendritic cell-based cancer vaccine potency. Exp. Mol. Med. 44: 340-349. https://doi.org/10.3858/emm.2012.44.5.038
- Cho, N. H., T. C. Cheong, J. H. Min, J. H. Wu, S. J. Lee, D. Kim, J. S. Yang, S. Kim, Y. K. Kim, and S. Y. Seong. 2011. A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy. Nat. Nanotechnol. 6: 675-682. https://doi.org/10.1038/nnano.2011.149
- Noh, Y. W., J. H. Hong, S. M. Shim, H. S. Park, H. H. Bae, E. K. Ryu, J. H. Hwang, C. H. Lee, S. H. Cho, M. H. Sung, H. Poo, and Y. T. Lim. 2013. Polymer nanomicelles for efficient mucus delivery and antigen-specific high mucosal immunity. Angew. Chem. Int. Ed. Engl. 52: 7684-7689. https://doi.org/10.1002/anie.201302881
- Prasad, S., V. Cody, J. K. Saucier-Sawyer, W. M. Saltzman, C. T. Sasaki, R. L. Edelson, M. A. Birchall, and D. J. Hanlon. 2011. Polymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy. Nanomedicine 7: 1-10. https://doi.org/10.1016/j.nano.2010.07.002
- Silva, J. M., M. Videira, R. Gaspar, V. Preat, and H. F. Florindo. 2013. Immune system targeting by biodegradable nanoparticles for cancer vaccines. J. Control. Release 168: 179-199. https://doi.org/10.1016/j.jconrel.2013.03.010
- Xiang, S. D., K. Wilson, S. Day, M. Fuchsberger, and M. Plebanski. 2013. Methods of effective conjugation of antigens to nanoparticles as non-inflammatory vaccine carriers. Methods 60: 232-241. https://doi.org/10.1016/j.ymeth.2013.03.036
- Nembrini, C., A. Stano, K. Y. Dane, M. Ballester, A. J. van der Vlies, B. J. Marsland, M. A. Swartz, and J. A. Hubbell. 2011. Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination. Proc. Natl. Acad. Sci. USA 108: E989-997. https://doi.org/10.1073/pnas.1104264108
- Andrade, F., D. Rafael, M. Videira, D. Ferreira, A. Sosnik, and B. Sarmento. 2013. Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases. Adv. Drug Deliv. Rev. In press : http://dx.doi.org/10.1016/j.addr. 2013.07.020
- Suh, W. H., K. S. Suslick, G. D. Stucky, and Y. H. Suh. 2009. Nanotechnology, nanotoxicology, and neuroscience. Prog. Neurobiol. 87: 133-170. https://doi.org/10.1016/j.pneurobio.2008.09.009
- Zhang, L., F. X. Gu, J. M. Chan, A. Z. Wang, R. S. Langer, and O. C. Farokhzad. 2008. Nanoparticles in medicine: therapeutic applications and developments. Clin. Pharmacol. Ther. 83: 761-769. https://doi.org/10.1038/sj.clpt.6100400
- Kotagiri, N., J. S. Lee, and J. W. Kim. 2013. Selective pathogen targeting and macrophage evading carbon nanotubes through dextran sulfate coating and PEGylation for photothermal theranostics. J. Biomed. Nanotechnol. 9: 1008-1016. https://doi.org/10.1166/jbn.2013.1531
- Kanekiyo, M., C. J. Wei, H. M. Yassine, P. M. McTamney, J. C. Boyington, J. R. Whittle, S. S. Rao, W. P. Kong, L. Wang, and G. J. Nabel. 2013. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature 499: 102-106. https://doi.org/10.1038/nature12202
- Perry, J. L., K. G. Reuter, M. P. Kai, K. P. Herlihy, S. W. Jones, J. C. Luft, M. Napier, J. E. Bear, and J. M. DeSimone. 2012. PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics. Nano Lett. 12: 5304-5310. https://doi.org/10.1021/nl302638g
- Kim, J. H., Y. W. Noh, M. B. Heo, M. Y. Cho, and Y. T. Lim. 2012. Multifunctional hybrid nanoconjugates for efficient in vivo delivery of immunomodulating oligonucleotides and enhanced antitumor immunity. Angew. Chem. Int. Ed. Engl. 51: 9670-9673. https://doi.org/10.1002/anie.201204989
- Demento, S. L., S. C. Eisenbarth, H. G. Foellmer, C. Platt, M. J. Caplan, W. Mark Saltzman, I. Mellman, M. Ledizet, E. Fikrig, R. A. Flavell, and T. M. Fahmy. 2009. Inflammasomeactivating nanoparticles as modular systems for optimizing vaccine efficacy. Vaccine 27: 3013-3021. https://doi.org/10.1016/j.vaccine.2009.03.034
- Diwan, M., M. Tafaghodi, and J. Samuel. 2002. Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres. J. Control. Release 85: 247-262. https://doi.org/10.1016/S0168-3659(02)00275-4
- Clawson, C., C. T. Huang, D. Futalan, D. M. Seible, R. Saenz, M. Larsson, W. Ma, B. Minev, F. Zhang, M. Ozkan, C. Ozkan, S. Esener, and D. Messmer. 2010. Delivery of a peptide via poly(D,L-lactic-co-glycolic) acid nanoparticles enhances its dendritic cell-stimulatory capacity. Nanomedicine 6: 651-661. https://doi.org/10.1016/j.nano.2010.03.001
- Shen, H., A. L. Ackerman, V. Cody, A. Giodini, E. R. Hinson, P. Cresswell, R. L. Edelson, W. M. Saltzman, and D. J. Hanlon. 2006. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsu lated in biodegradable nanoparticles. Immunology 117: 78-88. https://doi.org/10.1111/j.1365-2567.2005.02268.x
- Liu, S. Y., W. Wei, H. Yue, D. Z. Ni, Z. G. Yue, S. Wang, Q. Fu, Y. Q. Wang, G. H. Ma, and Z. G. Su. 2013. Nanoparticles-based multi-adjuvant whole cell tumor vaccine for cancer immunotherapy. Biomaterials 34: 8291-8300. https://doi.org/10.1016/j.biomaterials.2013.07.020
- Shima, F., T. Akagi, T. Uto, and M. Akashi, 2013. Manipulating the antigen-specific immune response by the hydrophobicity of amphiphilic poly(gamma-glutamic acid) nanoparticles. Biomaterials 34: 9709-9716. https://doi.org/10.1016/j.biomaterials.2013.08.064
- Reddy, S. T., A. J. van der Vlies, E. Simeoni, V. Angeli, G. J. Randolph, C. P. O'Neil, L. K. Lee, M. A. Swartz, and J. A. Hubbell. 2007. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat. Biotechnol. 25: 1159-1164. https://doi.org/10.1038/nbt1332
- Bachmann, M. F. and G. T. Jennings. 2010. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat. Rev. Immunol. 10: 787-796. https://doi.org/10.1038/nri2868
- Foged, C., B. Brodin, S. Frokjaer, and A. Sundblad. 2005. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int. J. Pharm. 298: 315-322. https://doi.org/10.1016/j.ijpharm.2005.03.035
- Mottram, P. L., D. Leong, B. Crimeen-Irwin, S. Gloster, S. D. Xiang, J. Meanger, R. Ghildyal, N. Vardaxis, and M. Plebanski. 2007. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus. Mol. Pharm. 4: 73-84. https://doi.org/10.1021/mp060096p
- Thurn, K. T., E. Brown, A. Wu, S. Vogt, B. Lai, J. Maser, T. Paunesku, and G. E. Woloschak. 2007. Nanoparticles for applications in cellular imaging. Nanoscale Res. Lett. 2: 430-441. https://doi.org/10.1007/s11671-007-9081-5
- Yan, W., W. Chen, and L. Huang. 2008. Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine. J. Control. Release 130: 22-28. https://doi.org/10.1016/j.jconrel.2008.05.005
- Venkataraman, S., J. L. Hedrick, Z. Y. Ong, C. Yang, P. L. Ee, P. T. Hammond, and Y. Y. Yang. 2011. The effects of polymeric nanostructure shape on drug delivery. Adv. Drug Deliv. Rev. 63: 1228-1246. https://doi.org/10.1016/j.addr.2011.06.016
- Florez, L., C. Herrmann, J. M. Cramer, C. P. Hauser, K. Koynov, K. Landfester, D. Crespy, and V. Mailander. 2012. How shape influences uptake: interactions of anisotropic polymer nanoparticles and human mesenchymal stem cells. Small 8: 2222-2230. https://doi.org/10.1002/smll.201102002
- Alexis, F., E. Pridgen, L. K. Molnar, and O. C. Farokhzad. 2008. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5: 505-515. https://doi.org/10.1021/mp800051m
- Kelly, C., C. Jefferies, and S. A. Cryan. 2011. Targeted liposomal drug delivery to monocytes and macrophages. J. Drug Deliv. 2011: 727241.
- Nguyen, D. N., K. P. Mahon, G. Chikh, P. Kim, H. Chung, A. P. Vicari, K. T. Love, M. Goldberg, S. Chen, A. M. Krieg, J. Chen, R. Langer, and D. G. Anderson. 2012. Lipid-derived nanoparticles for immunostimulatory RNA adjuvant delivery. Proc. Natl. Acad. Sci. USA 109: E797-803. https://doi.org/10.1073/pnas.1121423109
- Geissmann, F., S. Jung, and D. R. Littman. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82. https://doi.org/10.1016/S1074-7613(03)00174-2
- Lee, I. H., H. K. Kwon, S. An, D. Kim, S. Kim, M. K. Yu, J. H. Lee, T. S. Lee, S. H. Im, and S. Jon. 2012. Imageable antigen-presenting gold nanoparticle vaccines for effective cancer immunotherapy in vivo. Angew. Chem. Int. Ed. Engl. 51: 8800-8805. https://doi.org/10.1002/anie.201203193
Cited by
- Development of a Novel Nanoparticle-based Therapeutic Vaccine for Breast Cancer Immunotherapy vol.8, pp.None, 2013, https://doi.org/10.1016/j.provac.2014.07.011
- Revolutionary impact of nanovaccines on immunotherapy vol.2, pp.2, 2013, https://doi.org/10.1016/j.nhtm.2014.11.058
- Stem cell technology and engineering for cancer treatment vol.2, pp.6, 2013, https://doi.org/10.7603/s40730-015-0013-1
- Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics vol.12, pp.7, 2015, https://doi.org/10.1517/17425247.2015.1042857
- Gold nanoparticles and vaccine development vol.14, pp.9, 2013, https://doi.org/10.1586/14760584.2015.1064772
- Fungi as an efficient mycosystem for the synthesis of metal nanoparticles: progress and key aspects of research vol.37, pp.11, 2013, https://doi.org/10.1007/s10529-015-1901-6
- The role of nanotechnology in control of human diseases: perspectives in ocular surface diseases vol.36, pp.5, 2016, https://doi.org/10.3109/07388551.2015.1036002
- The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction vol.11, pp.6, 2016, https://doi.org/10.2217/nnm.16.5
- Current in vitro approaches to assess nanoparticle interactions with lung cells vol.11, pp.18, 2013, https://doi.org/10.2217/nnm-2016-0199
- Immunological properties of gold nanoparticles vol.8, pp.3, 2013, https://doi.org/10.1039/c6sc03631g
- Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy vol.8, pp.None, 2017, https://doi.org/10.3389/fimmu.2017.00774
- Enhancement of Adjuvant Functions of Natural Killer T Cells Using Nanovector Delivery Systems: Application in Anticancer Immune Therapy vol.8, pp.None, 2013, https://doi.org/10.3389/fimmu.2017.00879
- Application of nanostructured drug delivery systems in immunotherapy of cancer: a review vol.45, pp.1, 2013, https://doi.org/10.1080/21691401.2016.1178136
- The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies vol.4, pp.None, 2013, https://doi.org/10.3389/fmolb.2017.00052
- Triple helix networks matching knowledge demand and supply in seven Dutch horticulture Greenport regions vol.119, pp.1, 2013, https://doi.org/10.7896/j.1052
- Cancer resistance to treatment and antiresistance tools offered by multimodal multifunctional nanoparticles vol.8, pp.1, 2017, https://doi.org/10.1186/s12645-017-0030-4
- High adjuvant activity of layered double hydroxide nanoparticles and nanosheets in anti-tumour vaccine formulations vol.47, pp.9, 2013, https://doi.org/10.1039/c7dt03725b
- pH/hypoxia programmable triggered cancer photo-chemotherapy based on a semiconducting polymer dot hybridized mesoporous silica framework vol.9, pp.37, 2013, https://doi.org/10.1039/c8sc02408a
- A Novel Human Papillomavirus 16 L1 Pentamer-Loaded Hybrid Particles Vaccine System: Influence of Size on Immune Responses vol.10, pp.42, 2013, https://doi.org/10.1021/acsami.8b11556
- Enhancing Protective Efficacy of Poultry Vaccines through Targeted Delivery of Antigens to Antigen-Presenting Cells vol.6, pp.4, 2013, https://doi.org/10.3390/vaccines6040075
- Functional Nanomaterials Optimized to Circumvent Tumor Immunological Tolerance vol.29, pp.3, 2019, https://doi.org/10.1002/adfm.201806087
- Physicochemical properties of particulate vaccine adjuvants: their pivotal role in modulating immune responses vol.49, pp.3, 2013, https://doi.org/10.1007/s40005-018-0406-4
- Nanoparticles: Properties and Applications in Cancer Immunotherapy vol.25, pp.17, 2013, https://doi.org/10.2174/1381612825666190708214240
- Mannose functionalized plain and endosomolytic nanocomposite(s)-based approach for the induction of effective antitumor immune response in C57BL/6 mice melanoma model vol.45, pp.7, 2013, https://doi.org/10.1080/03639045.2019.1593442
- Gold nanoparticles in chemo-, immuno-, and combined therapy: review [Invited] vol.10, pp.7, 2013, https://doi.org/10.1364/boe.10.003152
- Microfluidics-Assisted Size Tuning and Biological Evaluation of PLGA Particles vol.11, pp.11, 2013, https://doi.org/10.3390/pharmaceutics11110590
- Modulation of Nanostructure-Based Lipopolysaccharide Active Immunotherapy in Cancer: Size and Composition Determine Short- and Long-Term Tolerability vol.16, pp.11, 2013, https://doi.org/10.1021/acs.molpharmaceut.9b00631
- A nano-based thermotherapy for cancer stem cell-targeted therapy vol.8, pp.18, 2013, https://doi.org/10.1039/d0tb00311e
- Nanotechnology for COVID-19: Therapeutics and Vaccine Research vol.14, pp.7, 2013, https://doi.org/10.1021/acsnano.0c04006
- Silk Fibroin Nanoadjuvant as a Promising Vaccine Carrier to Deliver the FimH-IutA Antigen for Urinary Tract Infection vol.6, pp.8, 2013, https://doi.org/10.1021/acsbiomaterials.0c00736
- Nanotechnological strategies for systemic microbial infections treatment: A review vol.589, pp.None, 2013, https://doi.org/10.1016/j.ijpharm.2020.119780
- Emerging advances in synthetic cancer nano-vaccines: opportunities and challenges vol.19, pp.11, 2013, https://doi.org/10.1080/14760584.2020.1858058
- An Antigen‐Delivery Protein Nanoparticle Combined with Anti‐PD‐1 Checkpoint Inhibitor Has Curative Efficacy in an Aggressive Melanoma Model vol.3, pp.12, 2020, https://doi.org/10.1002/adtp.202000122
- Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death vol.12, pp.12, 2013, https://doi.org/10.3390/pharmaceutics12121165
- Enhancing Cancer Immunotherapy Treatment Goals by Using Nanoparticle Delivery System vol.16, pp.None, 2021, https://doi.org/10.2147/ijn.s295300
- The Use of Nanobiotechnology in Immunology and Vaccination vol.9, pp.2, 2021, https://doi.org/10.3390/vaccines9020074
- The Potential of Calcium Phosphate Nanoparticles as Adjuvants and Vaccine Delivery Vehicles vol.8, pp.None, 2013, https://doi.org/10.3389/fmats.2021.788373
- Nanoparticles in cancer immunotherapies: An innovative strategy vol.37, pp.2, 2013, https://doi.org/10.1002/btpr.3070
- Enhancing the specific T cell immune response against micro- and nanoparticle immobilized antigen vol.11, pp.4, 2013, https://doi.org/10.15789/2220-7619-ets-1374
- Delivery of a Cancer-Testis Antigen-Derived Peptide Using Conformationally Restricted Dipeptide-Based Self-Assembled Nanotubes vol.18, pp.10, 2013, https://doi.org/10.1021/acs.molpharmaceut.1c00451
- Brief on Recent Application of Liposomal Vaccines for Lower Respiratory Tract Viral Infections: From Influenza to COVID-19 Vaccines vol.14, pp.11, 2013, https://doi.org/10.3390/ph14111173